Boditech Med Inc. (KOSDAQ:206640)

Market Cap	257.91B -26.5%
Revenue (ttm)	151.75B +7.0%
Net Income	27.23B -0.3%
EPS	1,250.34 +0.7%
Shares Out	21.78M
PE Ratio	9.47
Forward PE	n/a
Dividend	150.00 (1.29%)
Ex-Dividend Date	Mar 31, 2026

Volume	73,061
Average Volume	113,294
Open	11,800
Previous Close	11,590
Day's Range	11,550 - 11,960
52-Week Range	10,970 - 18,670
Beta	0.33
RSI	42.40
Earnings Date	Mar 25, 2026

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 541
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.